The Mood-stabilizing effects of electroconvulsive therapy

Journal of ECT

Volumn 30, Issue 4, 2014, Pages 275-282

  Medda, Pierpaolo ^a   Toni, Cristina ^b   Perugi, Giulio ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

Author keywords

Bipolar depression; Electroconvulsive therapy; Mania; Mixed state; Mood stabilizer; Relapse

Indexed keywords

CHLORPROMAZINE; LITHIUM; MOOD STABILIZER; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANGER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL FEATURE; CONFUSION; DELIRIUM; DISEASE COURSE; DISEASE SEVERITY; DISORIENTATION; ELECTROCONVULSIVE THERAPY; EUPHORIA; FOLLOW UP; HUMAN; HYPOMANIA; IRRITABILITY; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; MENTAL INSTABILITY; MORBIDITY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PROPHYLAXIS; RAPID CYCLING BIPOLAR DISORDER; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SURVIVAL TIME; SUSPICIOUSNESS; THERAPY EFFECT; TREATMENT RESPONSE; MOOD DISORDERS; PSYCHOLOGY;

BIPOLAR DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; MOOD DISORDERS; RECURRENCE;

EID: 84928306077     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0000000000000160     Document Type: Review

References (102)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd ed. New York: Oxford University Press; 2007.
2. Passione R. UGO CERLETTI - Il Romanzo Dell'elettroshock, Aliberti Editore, Reggio Emilia; 2007.
3. Shorter D, Healy D. Shock Therapy: A History of Electroconvulsive Therapy in Mental Illness. New Brunswick, New Jersey and London: Rutgers University Press; 2007.
4. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003; 361: 799-808.
5. Loo C, Katalinic N, Mitchell PB, et al. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord. 2011; 132: 1-13.
6. Kho KH, van Vreeswijk MF, Simpson S, et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT. 2003; 19: 139-147.
7. Dierckx B, Heijnen WT, van den Broek WW, et al. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012; 14: 146-150.
8. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry. 1994; 151: 169-176.
9. Valenti M, Benabarre A, Garcia-Amador M, et al. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry. 2008; 23: 53-56.
10. Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003; 5: 421-433.
11. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. 2001; 158: 1265-1270.
12. Ghaemi SN Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers? Am J Psychiatry. 2008; 165: 300-302.
13. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006; 163: 232-239.
14. Ahlfors UG, Baastrup PC, Dencker SJ, et al. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr Scand. 1981; 64: 226-237.
15. Nelson LA, Swartz CM. Melancholic symptoms during concurrent olanzapine and fluoxetine. Ann Clin Psychiatry. 2000; 12: 167-170.
16. Sienaert P, Lambrichts L, Dols A, et al. Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review. Bipolar Disord. 2012; 15: 61-69.
17. Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008; 22: 343-396.
18. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007; 356: 1711-1722.
19. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995; 152: 1130-1138.
20. Post RM, Altshuler LL, Frye MA, et al. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord. 2001; 3: 259-265.
21. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. 2003; 5: 407-420.
22. Perry PJ Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord. 1996; 39: 1-6.
23. Anderson IM Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000; 58: 19-36.
24. Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 2001; 3: 95-104.
25. Grunhaus L, Schreiber S, Dolberg OT, et al. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 2002; 4(Suppl. 1): 91-93.
26. Zornberg GL, Pope HG Jr Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol. 1993; 13: 397-408.
27. Homan S, Lachenbruch PA, Winokur G, et al. An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression. Psychol Med. 1982; 12: 615-624.
28. Sackeim HA, Prudic J. Length of the ECT course in bipolar and unipolar depression. J ECT. 2005; 21: 195-197.
29. Sienaert P, Vansteelandt K, Demyttenaere K, et al. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord. 2009; 11: 418-424.
30. Perris C, d'Elia G. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses: X. Mortality, suicide and life-cycles. Acta Psychiatr Scand Suppl. 1966; 194: 172-189.
31. Medda P, Perugi G, Zanello S, et al. Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord. 2009; 118: 55-59.
32. Bailine S, Fink M, Knapp R, et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand. 2010; 121: 431-436.
33. Fink M. What was learned: studies by the consortium for research in ECT (CORE) 1997-2011. Acta Psychiatr Scand. 2014; 129: 417-426.
34. Andrade C, Gangadhar BN, Swaminath G, et al. Mania as a side effect of electroconvulsive therapy. Convuls Ther. 1988; 4: 81-83.
35. Lewis DA, Nasrallah HA. Mania associated with electroconvulsive therapy. J Clin Psychiatry. 1986; 47: 366-367.
36. Devanand DP, Sackeim HA, Decina P, et al. The development of mania and organic euphoria during ECT. J Clin Psychiatry. 1988; 49: 69-71.
37. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Racommendations for Treatment, Training and Privileging. 2nd ed Washington, DC: American Psychiatric Association; 2001.
38. Serby M. Manic reactions to ECT. Am J Geriatr Psychiatry. 2001; 9: 180.
39. Kukopulos A, Reginald D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980; 13: 156-167.
40. Angst J, Angst K, Baruffol I, et al. ECT-induced and drug-induced hypomania. Convuls Ther. 1992; 8: 179-185.
41. Henry C, Sorbara F, Lacoste J, et al. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry. 2001; 62: 249-255.
42. Medda P, Mauri M, Fratta S, et al. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy. J ECT. 2013; 29: 179-188.
43. Mohan TS, Tharyan P, Alexander J, et al. Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial. Bipolar Disord. 2009; 11: 126-134.
44. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988; 45: 727-732.
45. Danivas V, Behere RV Varambally S, et al. Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients. J ECT. 2010; 26: 278-279.
46. Jacobowski NL, Heckers S, Bobo WV Delirious mania: detection, diagnosis, and clinical management in the acute setting. J Psychiatr Pract. 2013; 19: 15-28.
47. Vanelle JM, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther. 1994; 10: 195-205.
48. Goodwin GM Evidence-based guidelines for treating bipolar disorder: revised second edtion - recommendations from the British Association for Psychopharmacology JPsychopharmacol. 2009; 23: 346-388.
49. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2012; 15: 1-44.
50. Schnur DB, Mukherjee S, Sackeim HA, et al. Symptomatic predictors of ECT response in medication-nonresponsive manic patients. J Clin Psychiatry. 1992; 53: 63-66.
51. Sikdar S, Kulhara P, Avasthi A, et al. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry. 1994; 164: 806-810.
52. Mukherjee S, Sackeim HA, Lee C. Unilateral ECT in the treatment of manic episodes. Convuls Ther. 1988; 4: 74-80.
53. Mukherjee S. Mechanisms of the antimanic effect of electroconvulsive therapy. Convuls Ther. 1989; 5: 227-243.
54. Hiremani RM, Thirthalli J, Tharayil BS, et al. Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania. Bipolar Disord. 2008; 10: 701-707.
55. Barekatain M, Jahangard L, Haghighi M, et al. Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients. J ECT. 2008; 24: 199-202.
56. Swann AC, Lafer B, Perugi G, et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 2013; 170: 31-42.
57. Angst J, Azorin JM, Bowden CL, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry. 2011; 68: 791-798.
58. Perugi G, Akiskal HS, Micheli C, et al. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord. 2001; 67: 105-114.
59. Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J ECT. 2000; 16: 32-37.
60. Stromgren LS Electroconvulsive therapy in Aarhus, Denmark, in 1984: its application in nondepressive disorders. Convuls Ther. 1988; 4: 306-313.
61. Gruber NP, Dilsaver SC, Shoaib AM, et al. ECT in mixed affective states: a case series. J ECT. 2000; 16: 183-188.
62. Medda P, Perugi G, Zanello S, et al. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT. 2009; 26: 82-86.
63. Ciapparelli A, Dell'Osso L, Tundo A, et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry. 2001; 62: 552-555.
64. Sackeim HA Continuation therapy following ECT: directions for future research. Psychopharmacol Bull. 1994; 30: 501-521.
65. Seager CP, Bird RL. Imipramine with electrical treatment in depression - a controlled trial. J Ment Sci. 1962; 108: 704-707.
66. Kay DW, Fahy T, Garside RF. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry. 1970; 117: 667-671.
67. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004; 55: 301-312.
68. Huuhka K, Viikki M, Tammentie T, et al. One-year follow-up after discontinuing maintenance electroconvulsive therapy. J ECT. 2012; 28: 225-228.
69. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001; 285: 1299-1307.
70. Huuhka M, Korpisammal L, Haataja R, et al. One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants. J ECT. 2004; 20: 179-185.
71. Birkenhager TK, Renes JW, Pluijms EM. One-year follow-up after successful ECT: a naturalistic study in depressed inpatients. J Clin Psychiatry. 2004; 65: 87-91.
72. Rasmussen KG, Mueller M, Rummans TA, et al. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009; 70: 232-237.
73. Lauritzen L, Odgaard K, Clemmesen L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand. 1996; 94: 241-251.
74. van Beusekom BS, van den Broek WW, Birkenhager TK. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study. J ECT. 2007; 23: 17-20.
75. Perugi G, Medda P, Zanello S, et al. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul. 2012; 5: 18-24.
76. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990; 31: 287-296.
77. O'Leary DA, Lee AS. Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry. 1996; 169: 423-429.
78. Sackeim HA The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001; 62(Suppl. 16): 10-17.
79. Aronson TA, Shukla S, Hoff A. Continuation therapy after ECT for delusional depression: a naturalistic study of prophylactic treatments and relapse. Convuls Ther. 1987; 3: 251-259.
80. Nordenskjold A, von Knorring L, Engstrom I. Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study. Depress Res Treat. 2011; 2011: 470985.
81. van den Broek WW, Birkenhager TK, Mulder PG, et al. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry. 2006; 67: 263-268.
82. Birkenhager TK, van den Broek WW, Mulder PG, et al. One-year outcome of psychotic depression after successful electroconvulsive therapy. J ECT. 2005; 21: 221-226.
83. Kerman E. Electroshock therapy, with special reference to relapses and an effort to prevent them. J Nerv Ment Dis. 1945; 102: 213-242.
84. Petrides G, Tobias KG, Kellner CH, et al. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011; 64: 129-140.
85. National Institute of Clinical Excellence (NICE). Guidance on the Use of Electroconvulsive Therapy. London, UK: NICE; 2003.
86. Cole C. T. R. NICE guidance may deny many patients treatment that they might benefit from. BMJ. 2003; 327: 621.
87. Procopio M. NICE guidelines andmaintenance ECT. Br J Psychiatry. 2003; 183: 13-17.
88. Freeman C. Editorial for ECT. J ECT. 2006; 22: 1-3.
89. Frederikse M, Petrides G, Kellner C. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report. J ECT. 2006; 22: 13-17.
90. Lisanby SH, Sampson S, Husain MM, et al. Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT. 2008; 24: 179-182.
91. Thornton JE, Mulsant BH, Dealy R, et al. A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther. 1990; 6: 121-129.
92. Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003; 19: 4-9.
93. Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT. 2003; 19: 10-16.
94. O'Connor DW, Gardner B, Presnell I, et al. The effectiveness of continuation-maintenance ECT in reducing depressed older patients' hospital re-admissions. J Affect Disord. 2009; 120: 62-66.
95. Sienaert P, Peuskens J. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord. 2006; 8: 304-306.
96. Gagne GG Jr, Furman MJ, Carpenter LL, et al. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry. 2000; 157: 1960-1965.
97. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006; 63: 1337-1344.
98. Navarro V, Gasto C, Torres X, et al. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry. 2008; 16: 498-505.
99. Minnai GP, Salis PG, Oppo R, et al. Effectiveness of maintenance electroconvulsive therapy in rapid-cycling bipolar disorder. J ECT. 2011; 27: 123-126.
100. Dias VV, Balanza-Martinez V, Soeiro-de-Souza MG, et al. Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. Acta Psychiatr Scand. 2012; 126: 315-331.
101. Lochmann van Bennekom MW, Gijsman HJ, Zitman FG. Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness. J Psychopharmacol. 2013; 27: 327-336.
102. Arana GW An overview of side effects caused by typical antipsychotics. J Clin Psychiatry. 2000; 61(Suppl. 8): 5-11.